Exponent (EXPO) VP Joseph Sala awarded 9,798 restricted stock units

Rhea-AI Filing Summary

Sala Joseph reported acquisition or exercise transactions in this Form 4 filing.

Exponent Inc reported that Group Vice President Joseph Sala received a grant of 9,798 Restricted Stock Units on March 13, 2026. These RSUs are a form of stock-based compensation, with each unit convertible into one share of Exponent common stock on a 1-for-1 basis.

Following this award, Sala holds 9,798 RSUs directly, all tied to Exponent common stock. The grant was made at no cash cost per unit and reflects routine executive equity compensation rather than an open-market stock purchase or sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sala Joseph

(Last) (First) (Middle)

149 COMMONWEALTH DRIVE

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group Vice President

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/13/2026		A		9,798		03/13/2030	03/13/2030	Common Stock	9,798	(2)	9,798	D

Explanation of Responses:

1. 1-for-1.

2. Not applicable.

	By: Wendy Whitehouse For: Joseph Sala	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Exponent (EXPO) executive Joseph Sala report in this Form 4?

Joseph Sala reported receiving a grant of 9,798 Restricted Stock Units as equity compensation. Each RSU represents a right to receive one share of Exponent common stock, increasing his stock-based stake without any open-market share purchase or sale.

How many Exponent (EXPO) RSUs did Joseph Sala receive and at what price?

Joseph Sala received 9,798 Restricted Stock Units at a stated price of $0.00 per unit. This indicates a compensation award rather than a cash purchase, giving him rights to future Exponent common shares on a 1-for-1 conversion basis.

What is the relationship between Joseph Sala’s RSUs and Exponent (EXPO) common stock?

Each of Joseph Sala’s 9,798 Restricted Stock Units is convertible into one share of Exponent common stock. The footnotes specify a 1-for-1 relationship, meaning his RSU holdings mirror an equivalent potential number of common shares when they settle.

Did Joseph Sala buy or sell Exponent (EXPO) shares in the market in this filing?

No open-market buy or sell transactions were reported. The Form 4 shows only an acquisition of 9,798 Restricted Stock Units as a grant, with no corresponding sales, purchases, or tax-withholding dispositions of Exponent common stock in the market.

How many Exponent (EXPO) RSUs does Joseph Sala hold after this grant?

After the reported grant, Joseph Sala holds 9,798 Restricted Stock Units directly. These RSUs represent his reported derivative interest tied to Exponent common stock in this filing, reflecting a routine equity compensation position rather than trading activity.